January 18, 2022
Amorphous nanoparticles are a new class of pharmaceutical dosage forms gaining traction in the drug development world. They are increasingly […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
January 14, 2022
Ascendia Pharmaceuticals participated in the virtual Nasdaq Opening Bell Ceremony on Monday, January 10, 2022 to celebrate the first day […]
READ MORE >December 22, 2021
Good manufacturing practices (GMP) are not limited to drugs that are approved to market by the FDA. GMP guidance also […]
READ MORE >